Skip to main content
Clinical Trials/JPRN-UMIN000054001
JPRN-UMIN000054001
Completed
未知

Organizing and developing evidence for PRO indicators for depression, anxiety, and premenstrual syndrome used in healthcare - Organizing and developing evidence for PRO indicators for depression, anxiety, and premenstrual syndrome used in healthcare

Chiba University0 sites400 target enrollmentMarch 30, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chiba University
Enrollment
400
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2024
End Date
March 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Depression is defined by a PHQ\-9 score of 15 points or higher, anxiety is defined by a GAD\-7 score of 15 points or higher, and premenstrual syndrome is defined by a score of 15 points or higher on the PHQ\-9\. People who fall under PMDD according to the PMDD rating scale 2\) People with gynecological diseases (fibroids, endometriosis, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials